Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
143.85B
Market cap143.85B
Price-Earnings ratio
19.87
Price-Earnings ratio19.87
Dividend yield
6.64%
Dividend yield6.64%
Average volume
35.34M
Average volume35.34M
High today
$25.87
High today$25.87
Low today
$24.94
Low today$24.94
Open price
$25.66
Open price$25.66
Volume
50.28M
Volume50.28M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.11
52 Week low$23.11

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $25.24. The company's market cap stands at 143.85B, with a P/E ratio of 19.87 and a dividend yield of 6.64%.

On 2026-06-18, Pfizer(PFE) stock moved within a range of $24.94 to $25.87. With shares now at $25.24, the stock is trading +1.2% above its intraday low and -2.4% below the session's peak.

Trading activity shows a volume of 50.28M, compared to an average daily volume of 35.34M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.

PFE News

TipRanks 22m
Pfizer reaffirms all components of FY26 guidance

Following the disclosure of Pfizer’s (PFE) CFO transition announcement on June 18, 2026, Pfizer is reaffirming its fiscal year 2026 guidance introduced December...

Investing.com 27m
Pfizer reafffirms 2026 guidance after CFO transition announcement - Investing.com

...

Pfizer reafffirms 2026 guidance after CFO transition announcement - Investing.com
Benzinga 58m
Pfizer Stock Drops Today As CFO Steps Down In August

Pfizer stock is among today’s weakest performers. Why are PFE shares down? Denton Plans To Exit For A Role Outside Healthcare Pfizer said that Dave Denton will...

Pfizer Stock Drops Today As CFO Steps Down In August

Analyst ratings

59%

of 29 ratings
Buy
34.5%
Hold
58.6%
Sell
6.9%

More PFE News

Nasdaq 7h
Pfizer CFO Dave Denton To Step Down; Names Cecile Guegan Interim Finance Chief

(RTTNews) - Pfizer Inc. (PFE) said on Thursday that Chief Financial Officer Dave Denton will leave the company on August 15 to purse an opportunity outside the...

Pfizer CFO Dave Denton To Step Down; Names Cecile Guegan Interim Finance Chief
TipRanks 7h
Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

Pfizer (PFE) announced that Dave Denton, CFO, will step down from his current role and leave the company on August 15 for a professional opportunity outside of...

Simply Wall St 1d
Pfizer Stock And Two AI Healthcare Plays That Look Mispriced

Artificial intelligence in healthcare is moving from theory to real-world impact just as central banks, inflation trends, and energy markets keep broader sentim...

Pfizer Stock And Two AI Healthcare Plays That Look Mispriced
TipRanks 2d
Rigel Deal for VEPPANU Cleared, Arvinas Receives Payment

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

24/7 Wall St. 2d
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? By David Moadel Published Jun 16, 3:21PM EDT Quick Read Moderna...

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Nasdaq 3d
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth

Key Points By 2029, Pfizer CEO Albert Bourla believes the company may return to high-single-digit growth. Recent settlements have pushed back the patent cliff...

Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
TipRanks 5d
Pfizer Pivots Hard: Obesity, Cancer Bets Tempt Investors

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Introducing TipRanks MCP for Agents Deliver institut...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.